DVCD AL denied for failing step therapy by Blue Cross Blue Shield?
Step-therapy denials usually flip when the appeal documents that prior alternatives were tried and failed, or were contraindicated, or aren't safe for the patient.
US health-plan appeal rights
Cite: Most US health plans have appeal rights under either the ACA, ERISA, or Medicare/Medicaid rules
Most US health plans are required by federal law to give you both an internal appeal (where the insurer reconsiders) and an external review (where an independent reviewer decides). The exact timelines and processes depend on what kind of plan you have — marketplace / employer group, self-funded, Medicare Advantage, or Medicaid MCO — but in every case there's a window after the denial during which you have the right to fight it.
What Blue Cross Blue Shield typically requires
Blue Cross Blue Shield's specific coverage criteria for dvcd al are defined in its own published medical/coverage policy and the FDA-approved prescribing label. A successful appeal documents that your medical records satisfy each criterion those sources list — confirmed diagnosis, any required prior treatments (with dates and outcomes), and clinical severity. If the exact criteria weren't included with your denial, request them in writing; your appeal then maps each requirement to the matching fact in your chart.
The Blue Cross Blue Shield angle on DVCD AL
## Why BCBS May Deny a Medical Device for Alcohol Use Disorder Under Step Therapy
Blue Cross Blue Shield plans use step therapy (also called "fail first") protocols to require that patients try one or more lower-cost or more established treatments before approving a requested device. A step-therapy denial means BCBS's coverage policy requires documented evidence that certain prior treatments were tried and were inadequate, ineffective, or contraindicated before the requested device will be authorized.
## Why This Denial Is Appealable
Many states have enacted step-therapy reform laws that limit a plan's ability to require step therapy when a clinician documents a specific clinical reason why the step treatment is inappropriate. Under ERISA, self-funded plans are not bound by state step-therapy laws, but they are still subject to the full-and-fair review requirement, which means the plan must evaluate your individual clinical circumstances. If you already tried a required step treatment — or if your prescriber documents a medical reason it is inappropriate for you — the step-therapy barrier falls.
## Federal Appeal Framework
- Internal appeal: File within the deadline on your denial notice. Request the complete step-therapy protocol BCBS applied to this device category.
- External review: Available after final internal denial. An IRO will assess whether BCBS's step-therapy application was clinically appropriate given your documented treatment history. The external-review window is approximately four months from the final adverse determination; expedited review is available when delay would jeopardize health.
## Concrete Appeal Steps
1. Obtain the full step-therapy policy from BCBS — it must specify which prior treatments are required and what constitutes an adequate trial. 2. Audit your medical records for any documented prior use of the required step treatments, including dates, dosages, duration, and outcomes or adverse effects. 3. If you already tried a required step treatment, compile that documentation and submit it directly — this alone may be sufficient to overturn the denial. 4. If a required step treatment is clinically inappropriate for you, have your prescriber document specifically why (e.g., medical contraindication, prior treatment failure, patient-specific clinical factors) without relying on numbers that may be wrong — reference your chart. 5. Check whether your state has a step-therapy override law (if you are in a fully insured plan).
## Documentation to Gather
- Diagnosis confirmation: Comprehensive chart notes establishing the diagnosis and current clinical status.
- Prior-treatment history: Dated records for each prior treatment tried — medication names, duration, prescriber notes on outcomes, and any documented adverse reactions or failures.
- Clinical severity: Prescriber assessment of the current severity of alcohol use disorder and the urgency of device access.
- Prescriber medical-necessity letter: A letter addressing each step in BCBS's protocol, either confirming the step was completed (with dates and outcomes) or explaining why it is medically inappropriate for this patient.
- Relevant guideline reference: A note from your prescriber referencing applicable clinical practice guidelines from a recognized organization (such as ASAM) that support the requested device as appropriate for your stage of treatment.
## Criteria-Mapping Structure
List each step-therapy requirement from BCBS's policy in a table. For each step, provide the chart date, prescriber name, and the specific documented outcome or medical reason for exception. This structured format allows the reviewer to verify compliance with each requirement without searching through unstructured records.
Next steps
- Find the date on the denial letter — your appeal window starts there.
- Read your plan's Summary of Benefits and Coverage (SBC) for the specific deadlines.
- Request the insurer's claim file in writing — they must provide it.
- Submit your appeal in writing with new clinical evidence and a physician statement.
Get the letter drafted
DenialHelp drafts your appeal in 5 minutes — $40 list price, $30 for your first letter (use code SEO25). We cite the federal regs and the specific clinical evidence your plan responds to. Your physician signs and sends.
Start my appeal — $30 with code SEO25 →Related appeal guides
- Blue Cross Blue Shield denied for failing step therapy of 17ohp Compounded
- Blue Cross Blue Shield denied for failing step therapy of AAT Augmentation
- Blue Cross Blue Shield denied for failing step therapy of Amphetamine Stimulant Prodrug
- Blue Cross Blue Shield denied for failing step therapy of Anti Cd 20 Ocrevus